Featured

The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: A randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial 

Published in 2023 this randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial assessed for safety and tolerability of NMN on metabolic parameters that relate to aging. The results confirmed that orally administered NMN is absorbed  and quickly converted into NAD in human blood.  NAD blood levels were increased in a dose dependent manner.   References: Yi …

The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: A randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial  Read More »

Effects of Spermidine Supplementation on Cognition and Biomarkers in Older Adults with Subjective Cognitive Decline: A Randomized Clinical Trial 

This study known as the SmartAge study was a monocenter, randomized, double-masked, placebo-controlled phase 2b trial. The intervention included 89 participants (aged 60-90 years old) and 12-month dietary spermidine supplementation. Researchers suggest that supplementation with dietary spermidine might not act as a memory booster, but rather prevent age-related memory impairment and development of AD.  References: …

Effects of Spermidine Supplementation on Cognition and Biomarkers in Older Adults with Subjective Cognitive Decline: A Randomized Clinical Trial  Read More »

Scroll to Top